CME Medical Grand Rounds ~ Best Practices in the Treatment of Patients with Multiple Myeloma: Consid

EVENT DETAILS AND REGISTRATION

Date:October 27, 2015

Time: 12:00 PM - 01:00 PM (PT)

Location:Conference Room B

Event Is:

  • Select optimal treatments for patients with relapsed/refractory multiple myeloma using current treatment guidelines and emerging therapeutic options
  • Discuss emerging data on promising investigational therapies for relapsed/refractory multiple myeloma
  • Manage the adverse effects of agents used to treat patients with multiple myeloma

Presenters:William Bensinger, MD

ADDITIONAL DETAILS:

Objectives:

  • Select optimal treatments for patients with relapsed/refractory multiple myeloma using current treatment guidelines and emerging therapeutic options
  • Discuss emerging data on promising investigational therapies for relapsed/refractory multiple myeloma
  • Manage the adverse effects of agents used to treat patients with multiple myeloma

Who should attend:

Physicians, registered nurses, pharmacists and all other health care professionals interested in the subject matter

Sponsor(s):Educational Grant from Celgene Corporation, Millennium: The Takeda Oncology Company and Onyx Pharmaceuticals

CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: First Come First Serve

Contact:

CME Department